STAT3 and melanoma: Csomós, I., et al. [55] have indicated that chelidonine (22) arrests the G2/S phase of melanoma cells by inhibiting the phosphorylation of complexine and serine in the STAT3 signaling pathway in human melanoma cells, thus inhibiting melanoma.